ABSTRACT
The incidence of superficial and particularly deep mycotic infections has greatly increased over the last decade primarily attributable to a much larger population of immunosuppressed patients who are frequently on broad spectrum antibiotics and are managed with intravascular catheters and other devices that predispose them to infection.
